A01696 Summary:

BILL NOA01696B
 
SAME ASSAME AS S02465-B
 
SPONSORHunter
 
COSPNSRRaga
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L
 
Requires certain insurance policies allow patients additional screenings for breast cancer when the provider deems such screening is necessary under nationally recognized clinical practice guidelines.
Go to top    

A01696 Actions:

BILL NOA01696B
 
01/17/2023referred to insurance
01/03/2024referred to insurance
03/15/2024amend and recommit to insurance
03/15/2024print number 1696a
05/15/2024amend (t) and recommit to insurance
05/15/2024print number 1696b
Go to top

A01696 Committee Votes:

Go to top

A01696 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A01696 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         1696--B
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 17, 2023
                                       ___________
 
        Introduced  by  M.  of  A. HUNTER, RAGA -- read once and referred to the
          Committee on Insurance -- recommitted to the Committee on Insurance in
          accordance with Assembly Rule 3, sec. 2 -- committee discharged,  bill
          amended,  ordered reprinted as amended and recommitted to said commit-
          tee -- again reported from said  committee  with  amendments,  ordered
          reprinted as amended and recommitted to said committee
 
        AN  ACT  to  amend  the  insurance law, in relation to requiring certain
          insurance policies allow patients  additional  screenings  for  breast
          cancer  when  the  provider  deems  such  screening is necessary under
          nationally recognized clinical practice guidelines
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subparagraph  (A)  of  paragraph  11 of subsection (i) of
     2  section 3216 of the insurance law, as amended by chapter 414 of the laws
     3  of 2017, is amended to read as follows:
     4    (A) Every policy that provides  coverage  for  hospital,  surgical  or
     5  medical  care  shall  provide  the  following  coverage  for mammography
     6  screening for occult breast cancer:
     7    (i) upon the recommendation of a physician, a mammogram, which may  be
     8  provided  by breast tomosynthesis, at any age for covered persons having
     9  a prior history of breast cancer or who have  a  first  degree  relative
    10  with a prior history of breast cancer;
    11    (ii)  a  single  baseline  mammogram,  which may be provided by breast
    12  tomosynthesis, for covered persons aged thirty-five through thirty-nine,
    13  inclusive; [and]
    14    (iii) an annual mammogram, which may be provided by breast tomosynthe-
    15  sis, for covered persons aged forty and older; and
    16    (iv) upon the recommendation of a physician, screening and  diagnostic
    17  imaging, including diagnostic mammograms, breast ultrasounds, or magnet-
    18  ic  resonance  imaging,  recommended  by  nationally recognized clinical
    19  practice guidelines for the detection of breast cancer. For the purposes
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02639-08-4

        A. 1696--B                          2
 
     1  of this item, "nationally recognized clinical practice guidelines" means
     2  evidence-based clinical practice guidelines  informed  by  a  systematic
     3  review  of  evidence  and  an  assessment  of the benefits, and risks of
     4  alternative  care options intended to optimize patient care developed by
     5  independent organizations or medical professional societies utilizing  a
     6  transparent  methodology  and reporting structure and with a conflict of
     7  interest policy.
     8    § 2. Subparagraph (A) of paragraph 11 of  subsection  (l)  of  section
     9  3221  of  the  insurance  law,  as amended by chapter 143 of the laws of
    10  2019, is amended to read as follows:
    11    (A) Every insurer delivering a group or blanket policy  or  issuing  a
    12  group  or blanket policy for delivery in this state that provides cover-
    13  age for hospital, surgical or medical care shall provide  the  following
    14  coverage for mammography screening for occult breast cancer:
    15    (i)  upon the recommendation of a physician, a mammogram, which may be
    16  provided by breast tomosynthesis, at any age for covered persons  having
    17  a  prior  history  of  breast cancer or who have a first degree relative
    18  with a prior history of breast cancer;
    19    (ii) a single baseline mammogram, which  may  be  provided  by  breast
    20  tomosynthesis, for covered persons aged thirty-five through thirty-nine,
    21  inclusive;
    22    (iii) an annual mammogram, which may be provided by breast tomosynthe-
    23  sis, for covered persons aged forty and older; [and]
    24    (iv)  for  large  group  policies  that provide coverage for hospital,
    25  surgical or medical care, an annual mammogram for covered  persons  aged
    26  thirty-five through thirty-nine, inclusive, upon the recommendation of a
    27  physician,  subject to the insurer's determination that the mammogram is
    28  medically necessary; and
    29    (v) upon the recommendation of a physician, screening  and  diagnostic
    30  imaging, including diagnostic mammograms, breast ultrasounds, or magnet-
    31  ic  resonance  imaging,  recommended  by  nationally recognized clinical
    32  practice guidelines for the detection of breast cancer. For the purposes
    33  of this item, "nationally recognized clinical practice guidelines" means
    34  evidence-based clinical practice guidelines  informed  by  a  systematic
    35  review  of  evidence  and  an  assessment  of the benefits, and risks of
    36  alternative care options intended to optimize patient care developed  by
    37  independent  organizations or medical professional societies utilizing a
    38  transparent methodology and reporting structure and with a  conflict  of
    39  interest policy.
    40    §  3.  Paragraph  1 of subsection (p) of section 4303 of the insurance
    41  law, as amended by chapter 219 of the laws of 2011, subparagraph (A)  as
    42  amended  by chapter 414 of the laws of 2017, and subparagraphs (B), (C),
    43  (D), and (E) as amended by chapter 143 of the laws of 2019,  is  amended
    44  to read as follows:
    45    (1) A medical expense indemnity corporation, a hospital service corpo-
    46  ration or a health service corporation that provides coverage for hospi-
    47  tal,  surgical  or medical care shall provide the following coverage for
    48  mammography screening for occult breast cancer:
    49    (A) upon the recommendation of a physician, a mammogram, which may  be
    50  provided  by breast tomosynthesis, at any age for covered persons having
    51  a prior history of breast cancer or who have  a  first  degree  relative
    52  with a prior history of breast cancer;
    53    (B) a single baseline mammogram, which may be provided by breast tomo-
    54  synthesis,  for  covered  persons  aged thirty-five through thirty-nine,
    55  inclusive;

        A. 1696--B                          3

     1    (C) an annual mammogram, which may be provided by breast tomosythesis,
     2  for covered persons aged forty and older;
     3    (D)  for  large group contracts offered by a medical expense indemnity
     4  corporation, a hospital service corporation or a health  service  corpo-
     5  ration  that provide coverage for hospital, surgical or medical care, an
     6  annual mammogram for covered persons aged  thirty-five  through  thirty-
     7  nine,  inclusive, upon the recommendation of a physician, subject to the
     8  corporation's determination that the mammogram is  medically  necessary;
     9  [and]
    10    (E)  upon  the recommendation of a physician, screening and diagnostic
    11  imaging, including diagnostic mammograms, breast ultrasounds, or magnet-
    12  ic resonance imaging,  recommended  by  nationally  recognized  clinical
    13  practice guidelines for the detection of breast cancer. For the purposes
    14  of  this  subparagraph,  "nationally recognized clinical practice guide-
    15  lines" means evidence-based clinical practice guidelines informed  by  a
    16  systematic  review  of  evidence  and an assessment of the benefits, and
    17  risks of alternative care options  intended  to  optimize  patient  care
    18  developed by independent organizations or medical professional societies
    19  utilizing  a  transparent methodology and reporting structure and with a
    20  conflict of interest policy; and
    21    (F) The coverage required in this paragraph or paragraph two  of  this
    22  subsection shall not be subject to annual deductibles or coinsurance.
    23    §  4.  This  act shall take effect January 1, 2026  and shall apply to
    24  all policies and contracts issued, renewed, modified, altered or amended
    25  on or after such date.
Go to top